Accelerating Progress in Human Health and Scientific Research

Alex cofounded Parse Biosciences and leads the organization as its Chief Executive Officer. Alex is an experienced leader and technologist with a track record of pushing innovation in next-generation sequencing, machine learning, and predictive models of biology. As a Commercialization Fellow at the University of Washington, Alex co-invented the single cell technology that inspired Parse Biotechnologies’ foundational Evercode™ platform. Alex is an active technical leader and inventor with multiple publications in high-profile journals such as Cell and Science and several patents.

Alex received a Ph.D. in Electrical Engineering from the University of Washington and BSE in Electrical Engineering from the University of Michigan.

Charlie cofounded Parse Biosciences and leads as its Chief Technology Officer. Charlie is passionate about biology-based technology development, with over a decade of driving innovation in the field. Prior to Parse, he was at the University of Washington where he received several fellowships from the NIH and Fred Hutch Cancer Research Center. This work generated high-profile publications in Science and informed the core technology of Parse Biosciences. Previously, Charlie contributed to innovations in drug delivery and microscopy at the Wyss Institute at Harvard and the University of Pennsylvania.

Charlie received a Ph.D. in Bioengineering from the University of Washington and BSE in Biological Systems Engineering from Virginia Tech.